Lei Zhu

Lei Zhu holds a Master's degree in Chemistry from Syracuse University and a Bachelor of Science in Chemistry from Nanjing University. Lei Zhu has extensive experience in the pharmaceutical industry, currently serving as Executive Director at Mersana Therapeutics since April 2017, where responsibilities include managing activities related to antibody drug conjugate (ADC) warhead, linker, and DBS process development and manufacturing. Previously, Lei Zhu held roles at Millennium Pharmaceuticals as Sr. Scientist focusing on process development and management, at Bayer HealthCare and Boehringer Ingelheim as a Scientist specializing in process chemistry.